84 selected items - PubMed - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

My NCBI Sign In

Result Filters

<< First< Prev

Page of 5

Results: 1 to 20 of 84

1.

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC).

Souglakos J, Ziras N, Kakolyris S, Boukovinas I, Kentepozidis N, Makrantonakis P, Xynogalos S, Christophyllakis Ch, Kouroussis Ch, Vamvakas L, Georgoulias V, Polyzos A.

Br J Cancer. 2012 Jan 31;106(3):453-9. doi: 10.1038/bjc.2011.594. Epub 2012 Jan 12.

PMID:: 22240792; [PubMed - indexed for MEDLINE]

Related citations

2.

Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer.

Dotan E, Meropol NJ, Zhu F, Zambito F, Bove B, Cai KQ, Godwin AK, Golemis EA, Astsaturov I, Cohen SJ.

Br J Cancer. 2012 Feb 14;106(4):748-55. doi: 10.1038/bjc.2011.587. Epub 2012 Jan 12.

PMID:: 22240781; [PubMed - indexed for MEDLINE]

Related citations

3.

Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer.

Jehn CF, Böning L, Kröning H, Possinger K, Lüftner D.

Br J Cancer. 2012 Jan 17;106(2):274-8. doi: 10.1038/bjc.2011.554. Epub 2012 Jan 3.

PMID:: 22215062; [PubMed - indexed for MEDLINE]

Related citations

4.

Potential role of a navigator gene NAV3 in colorectal cancer.

Carlsson E, Ranki A, Sipilä L, Karenko L, Abdel-Rahman WM, Ovaska K, Siggberg L, Aapola U, Ässämäki R, Häyry V, Niiranen K, Helle M, Knuutila S, Hautaniemi S, Peltomäki P, Krohn K.

Br J Cancer. 2012 Jan 31;106(3):517-24. doi: 10.1038/bjc.2011.553. Epub 2011 Dec 15.

PMID:: 22173670; [PubMed - indexed for MEDLINE]

Related citations

5.

9. Cancers attributable to inadequate physical exercise in the UK in 2010.

Parkin DM.

Br J Cancer. 2011 Dec 6;105 Suppl 2:S38-41. doi: 10.1038/bjc.2011.482. No abstract available.

PMID:: 22158319; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

6.

6. Cancers attributable to dietary factors in the UK in 2010. III. Low consumption of fibre.

Parkin DM, Boyd L.

Br J Cancer. 2011 Dec 6;105 Suppl 2:S27-30. doi: 10.1038/bjc.2011.479. No abstract available.

PMID:: 22158316; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

7.

5. Cancers attributable to dietary factors in the UK in 2010. II. Meat consumption.

Parkin DM.

Br J Cancer. 2011 Dec 6;105 Suppl 2:S24-26. doi: 10.1038/bjc.2011.478. No abstract available.

PMID:: 22158315; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

8.

A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women.

Kabat GC, Kim MY, Strickler HD, Shikany JM, Lane D, Luo J, Ning Y, Gunter MJ, Rohan TE.

Br J Cancer. 2012 Jan 3;106(1):227-32. doi: 10.1038/bjc.2011.512. Epub 2011 Nov 29.

PMID:: 22127286; [PubMed - indexed for MEDLINE]

Related citations

9.

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer.

Zeestraten EC, Maak M, Shibayama M, Schuster T, Nitsche U, Matsushima T, Nakayama S, Gohda K, Friess H, van de Velde CJ, Ishihara H, Rosenberg R, Kuppen PJ, Janssen KP.

Br J Cancer. 2012 Jan 3;106(1):133-40. doi: 10.1038/bjc.2011.504. Epub 2011 Nov 22. Erratum in: Br J Cancer. 2012 Feb 14;106(4):792.

PMID:: 22108518; [PubMed - indexed for MEDLINE]

Related citations

10.

Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets.

Gilbert DC, Chalmers AJ, El-Khamisy SF.

Br J Cancer. 2012 Jan 3;106(1):18-24. doi: 10.1038/bjc.2011.498. Epub 2011 Nov 22. Review.

PMID:: 22108516; [PubMed - indexed for MEDLINE]

Related citations

11.

Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer.

Ferdinande L, Decaestecker C, Verset L, Mathieu A, Moles Lopez X, Negulescu AM, Van Maerken T, Salmon I, Cuvelier CA, Demetter P.

Br J Cancer. 2012 Jan 3;106(1):141-7. doi: 10.1038/bjc.2011.513. Epub 2011 Nov 22.

PMID:: 22108515; [PubMed - indexed for MEDLINE]

Related citations

12.

Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis.

Tsuji S, Midorikawa Y, Takahashi T, Yagi K, Takayama T, Yoshida K, Sugiyama Y, Aburatani H.

Br J Cancer. 2012 Jan 3;106(1):126-32. doi: 10.1038/bjc.2011.505. Epub 2011 Nov 17.

PMID:: 22095227; [PubMed - indexed for MEDLINE]

Related citations

13.

The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature.

Davies NJ, Batehup L, Thomas R.

Br J Cancer. 2011 Nov 8;105 Suppl 1:S52-73. doi: 10.1038/bjc.2011.423. Review.

PMID:: 22048034; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

14.

Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study.

Khan NF, Mant D, Carpenter L, Forman D, Rose PW.

Br J Cancer. 2011 Nov 8;105 Suppl 1:S29-37. doi: 10.1038/bjc.2011.420.

PMID:: 22048030; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

15.

The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study.

Gormley JA, Hegarty SM, O'Grady A, Stevenson MR, Burden RE, Barrett HL, Scott CJ, Johnston JA, Wilson RH, Kay EW, Johnston PG, Olwill SA.

Br J Cancer. 2011 Nov 8;105(10):1487-94. doi: 10.1038/bjc.2011.408. Epub 2011 Oct 11.

PMID:: 21989182; [PubMed - indexed for MEDLINE]

Related citations

16.

Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells.

Bose D, Zimmerman LJ, Pierobon M, Petricoin E, Tozzi F, Parikh A, Fan F, Dallas N, Xia L, Gaur P, Samuel S, Liebler DC, Ellis LM.

Br J Cancer. 2011 Nov 22;105(11):1759-67. doi: 10.1038/bjc.2011.449. Epub 2011 Nov 1.

PMID:: 22045189; [PubMed - indexed for MEDLINE]

Related citations

17.

Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancer.

Kanai M, Ishiguro H, Mori Y, Kitano T, Nishimura T, Matsumoto S, Yanagihara K, Chiba T, Toi M.

Br J Cancer. 2011 Nov 22;105(11):1693-6. doi: 10.1038/bjc.2011.398. Epub 2011 Oct 27.

PMID:: 22033274; [PubMed - indexed for MEDLINE]

Related citations

18.

Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial.

Melichar B, Casado E, Bridgewater J, Bennouna J, Campone M, Vitek P, Delord JP, Cerman J Jr, Salazar R, Dvorak J, Sguotti C, Urban P, Viraswami-Appanna K, Tan E, Tabernero J.

Br J Cancer. 2011 Nov 22;105(11):1646-53. doi: 10.1038/bjc.2011.438. Epub 2011 Oct 25.

PMID:: 22027708; [PubMed - indexed for MEDLINE]

Related citations

19.

Stem cells, quiescence and rectal carcinoma: an unexplored relationship and potential therapeutic target.

Buczacki S, Davies RJ, Winton DJ.

Br J Cancer. 2011 Oct 25;105(9):1253-9. doi: 10.1038/bjc.2011.362. Epub 2011 Sep 20. Review.

PMID:: 21934687; [PubMed - indexed for MEDLINE]

Related citations

20.

Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment.

Bennett L, Zhao Z, Barber B, Zhou X, Peeters M, Zhang J, Xu F, Wiezorek J, Douillard JY.

Br J Cancer. 2011 Nov 8;105(10):1495-502. doi: 10.1038/bjc.2011.409. Epub 2011 Oct 11.

PMID:: 21989186; [PubMed - indexed for MEDLINE]

Related citations

<< First< Prev

Page of 5

Supplemental Content

Filters: Manage Filters

Find related data

Recent activity

Clear Turn Off Turn On

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab ...
Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC).
Br J Cancer. 2012 Jan 31 ;106(3):453-9. doi: 10.1038/bjc.2011.594. Epub 2012 Jan 12 .

PubMed
ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid...
ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34(+) CD38(-) population to imatinib.
Exp Hematol. 2012 May ;40(5):367-78.e2. Epub 2012 Jan 10 .

PubMed
Proprioception and functional deficits of partial meniscectomized knees.
Proprioception and functional deficits of partial meniscectomized knees.
Eur J Phys Rehabil Med. 2012 Jun ;48(2):231-6. Epub 2012 Jan 12 .

PubMed
Risk of acute kidney injury in patients who undergo coronary angiography and car...
Risk of acute kidney injury in patients who undergo coronary angiography and cardiac surgery in close succession.
Eur Heart J. 2012 Jan 11. [Epub ahead of print]

PubMed
Prognostic impact of a chronic total occlusion in a non-infarct-related artery i...
Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial.
Eur Heart J. 2012 Mar ;33(6):768-75. Epub 2012 Jan 12 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Literature > PubMed

Write to the Help Desk